NYSE:MD Pediatrix Medical Group (MD) Stock Forecast, Price & News $13.36 +0.09 (+0.68%) (As of 05/26/2023 07:00 PM ET) Add Compare Share Share Today's Range$13.19▼$13.4650-Day Range$13.02▼$14.9852-Week Range$12.84▼$23.95Volume310,700 shsAverage Volume688,327 shsMarket Capitalization$1.12 billionP/E Ratio10.95Dividend YieldN/APrice Target$17.67 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Pediatrix Medical Group MarketRank™ ForecastAnalyst RatingHold2.40 Rating ScoreUpside/Downside32.2% Upside$17.67 Price TargetShort InterestHealthy4.67% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.07Based on 8 Articles This WeekInsider TradingSelling Shares$681,385 Sold Last QuarterProj. Earnings Growth10.42%From $1.44 to $1.59 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.60 out of 5 starsMedical Sector121st out of 1,010 stocksHospitals Industry3rd out of 3 stocks 3.2 Analyst's Opinion Consensus RatingPediatrix Medical Group has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on 2 buy ratings, 3 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $17.67, Pediatrix Medical Group has a forecasted upside of 32.2% from its current price of $13.36.Amount of Analyst CoveragePediatrix Medical Group has received no research coverage in the past 90 days. Previous Next 4.0 Short Interest Percentage of Shares Shorted4.67% of the float of Pediatrix Medical Group has been sold short.Short Interest Ratio / Days to CoverPediatrix Medical Group has a short interest ratio ("days to cover") of 5.8.Change versus previous monthShort interest in Pediatrix Medical Group has recently decreased by 5.24%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldPediatrix Medical Group does not currently pay a dividend.Dividend GrowthPediatrix Medical Group does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for MD. Previous Next 2.3 News and Social Media Coverage News SentimentPediatrix Medical Group has a news sentiment score of 0.07. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.76 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 8 news articles for Pediatrix Medical Group this week, compared to 3 articles on an average week.Search InterestOnly 1 people have searched for MD on MarketBeat in the last 30 days. This is a decrease of -88% compared to the previous 30 days.MarketBeat Follows3 people have added Pediatrix Medical Group to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Pediatrix Medical Group insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $681,385.00 in company stock.Percentage Held by InsidersOnly 2.00% of the stock of Pediatrix Medical Group is held by insiders.Percentage Held by Institutions95.99% of the stock of Pediatrix Medical Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for Pediatrix Medical Group are expected to grow by 10.42% in the coming year, from $1.44 to $1.59 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Pediatrix Medical Group is 10.95, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 121.30.Price to Earnings Ratio vs. SectorThe P/E ratio of Pediatrix Medical Group is 10.95, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 80.11.Price to Earnings Growth RatioPediatrix Medical Group has a PEG Ratio of 2.32. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioPediatrix Medical Group has a P/B Ratio of 1.25. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Pediatrix Medical Group (NYSE:MD) StockPediatrix Medical Group, Inc. engages in the provision of physician services. It includes newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care. The company was founded by Roger J. Medel in 1979 and is headquartered in Sunrise, FL.Read More Receive MD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pediatrix Medical Group and its competitors with MarketBeat's FREE daily newsletter. Email Address MD Stock News HeadlinesMay 29, 2023 | americanbankingnews.comInsider Selling: Pediatrix Medical Group, Inc. (NYSE:MD) Director Sells $437,580.00 in StockMay 24, 2023 | finance.yahoo.comWhy Pediatrix Medical Group, Inc. (NYSE:MD) Could Be Worth WatchingMay 29, 2023 | Stocks To Trade (Ad)15 A.I. Trading Opportunities a DayUsing our algorithm, we sift through 15,000 stocks every second. We generate 15 trading opportunities a day.May 24, 2023 | americanbankingnews.comShirley A. Weis Sells 17,993 Shares of Pediatrix Medical Group, Inc. (NYSE:MD) StockMay 18, 2023 | americanbankingnews.comPediatrix Medical Group (NYSE:MD) Earns Hold Rating from Analysts at StockNews.comMay 11, 2023 | americanbankingnews.comTruist Financial Lowers Pediatrix Medical Group (NYSE:MD) Price Target to $15.00May 9, 2023 | nasdaq.comTruist Securities Maintains Pediatrix Medical Group (MD) Hold RecommendationMay 9, 2023 | americanbankingnews.comAnalysts Set Pediatrix Medical Group, Inc. (NYSE:MD) Price Target at $18.20May 29, 2023 | Behind the Markets (Ad)Laser breakthrough could send stock soaring 2,467%Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...May 7, 2023 | americanbankingnews.comQ2 2023 EPS Estimates for Pediatrix Medical Group, Inc. (NYSE:MD) Raised by SVB LeerinkMay 6, 2023 | seekingalpha.comPediatrix: P&L Still Burdened From RCM Overhang, Reiterate HoldMay 5, 2023 | finance.yahoo.comPediatrix (MD) Down 4.2% Despite Q1 Earnings & Revenue BeatMay 5, 2023 | americanbankingnews.comPediatrix Medical Group (NYSE:MD) PT Lowered to $14.00May 5, 2023 | americanbankingnews.comQ2 2023 EPS Estimates for Pediatrix Medical Group, Inc. (NYSE:MD) Cut by AnalystMay 4, 2023 | msn.comLooking Into Pediatrix Medical Group's Return On Capital EmployedMay 4, 2023 | finance.yahoo.comPediatrix Board Appoints Sylvia Young as Independent DirectorMay 4, 2023 | americanbankingnews.comPediatrix Medical Group (NYSE:MD) PT Lowered to $15.00May 3, 2023 | finance.yahoo.comPediatrix Medical Group to Present at 2023 Bank of America Health Care ConferenceMay 3, 2023 | finance.yahoo.comQ1 2023 Pediatrix Medical Group Inc Earnings CallMay 2, 2023 | chron.comPediatrix Medical Group: Q1 Earnings SnapshotMay 2, 2023 | msn.comPediatrix Medical Group (MD) Tops Q1 Earnings and Revenue EstimatesMay 2, 2023 | americanbankingnews.comPediatrix Medical Group, Inc. Forecasted to Post Q1 2023 Earnings of $0.20 Per Share (NYSE:MD)May 1, 2023 | msn.comA Preview Of Pediatrix Medical Group's EarningsMay 1, 2023 | americanbankingnews.comPediatrix Medical Group (MD) Set to Announce Earnings on TuesdayApril 28, 2023 | americanbankingnews.comPediatrix Medical Group (NYSE:MD) Sets New 12-Month Low at $13.59April 26, 2023 | finance.yahoo.comPediatrix Medical Group (NYSE:MD) sheds US$74m, company earnings and investor returns have been trending downwards for past five yearsApril 26, 2023 | finance.yahoo.comPediatrix Medical Group 2023 First Quarter Conference Call/Webcast Scheduled for Tuesday, May 2, 2023See More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive MD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pediatrix Medical Group and its competitors with MarketBeat's FREE daily newsletter. Email Address MD Company Calendar Last Earnings10/28/2021Today5/29/2023Next Earnings (Estimated)8/03/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Hospitals Sub-IndustryHealth Care Services SectorMedical Current SymbolNYSE:MD Previous SymbolNYSE:PDX CUSIP58502B10 CIK893949 Webwww.mednax.com Phone(954) 384-0175Fax954-838-9961Employees5,250Year Founded1979Price Target and Rating Average Stock Price Forecast$17.67 High Stock Price Forecast$23.00 Low Stock Price Forecast$14.00 Forecasted Upside/Downside+32.2%Consensus RatingHold Rating Score (0-4)2.40 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)$1.22 Trailing P/E Ratio10.95 Forward P/E Ratio9.28 P/E Growth2.32Net Income$66.33 million Net Margins5.14% Pretax Margin6.58% Return on Equity13.85% Return on Assets5.18% Debt Debt-to-Equity Ratio0.82 Current Ratio1.44 Quick Ratio1.44 Sales & Book Value Annual Sales$1.97 billion Price / Sales0.57 Cash Flow$2.01 per share Price / Cash Flow6.64 Book Value$10.86 per share Price / Book1.23Miscellaneous Outstanding Shares83,760,000Free Float82,085,000Market Cap$1.12 billion OptionableOptionable Beta1.74 Social Links Key ExecutivesJames D. SwiftChief Executive Officer & DirectorCurtis B. PickertChief Operating Officer & Executive Vice PresidentC. Mark RichardsChief Financial Officer & Executive Vice PresidentReese H. ClarkSenior VP-Clinical Research & EducationDana Dreher-RodwellChief Compliance Officer & Vice PresidentKey CompetitorsSelect MedicalNYSE:SEMBiohavenNYSE:BHVNDeciphera PharmaceuticalsNASDAQ:DCPHReplimune GroupNASDAQ:REPLWarby ParkerNYSE:WRBYView All CompetitorsInsiders & InstitutionsProShare Advisors LLCSold 1,052 shares on 5/26/2023Ownership: 0.014%Mark S OrdanSold 33,000 sharesTotal: $437,580.00 ($13.26/share)Capital Impact Advisors LLCBought 2,393 shares on 5/23/2023Ownership: 0.049%Ameriprise Financial Inc.Sold 6,922 shares on 5/22/2023Ownership: 0.530%JPMorgan Chase & Co.Bought 20,166 shares on 5/18/2023Ownership: 0.149%View All Insider TransactionsView All Institutional Transactions MD Stock - Frequently Asked Questions Should I buy or sell Pediatrix Medical Group stock right now? 5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Pediatrix Medical Group in the last year. There are currently 3 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" MD shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MD, but not buy additional shares or sell existing shares. View MD analyst ratings or view top-rated stocks. What is Pediatrix Medical Group's stock price forecast for 2023? 5 brokers have issued twelve-month price targets for Pediatrix Medical Group's shares. Their MD share price forecasts range from $14.00 to $23.00. On average, they anticipate the company's stock price to reach $17.67 in the next year. This suggests a possible upside of 32.2% from the stock's current price. View analysts price targets for MD or view top-rated stocks among Wall Street analysts. How have MD shares performed in 2023? Pediatrix Medical Group's stock was trading at $14.86 on January 1st, 2023. Since then, MD stock has decreased by 10.1% and is now trading at $13.36. View the best growth stocks for 2023 here. Are investors shorting Pediatrix Medical Group? Pediatrix Medical Group saw a decrease in short interest in the month of April. As of April 15th, there was short interest totaling 4,070,000 shares, a decrease of 5.8% from the March 31st total of 4,320,000 shares. Based on an average trading volume of 768,900 shares, the days-to-cover ratio is currently 5.3 days. Approximately 5.0% of the company's stock are sold short. View Pediatrix Medical Group's Short Interest. When is Pediatrix Medical Group's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, August 3rd 2023. View our MD earnings forecast. How were Pediatrix Medical Group's earnings last quarter? Pediatrix Medical Group, Inc. (NYSE:MD) issued its quarterly earnings data on Thursday, October, 28th. The company reported $0.46 EPS for the quarter, topping the consensus estimate of $0.41 by $0.05. The firm earned $493 million during the quarter, compared to analyst estimates of $480.04 million. Pediatrix Medical Group had a net margin of 5.14% and a trailing twelve-month return on equity of 13.85%. The firm's revenue was up 7.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.33 EPS. What ETFs hold Pediatrix Medical Group's stock? ETFs with the largest weight of Pediatrix Medical Group (NYSE:MD) stock in their portfolio include SPDR S&P Health Care Services ETF (XHS), Invesco S&P SmallCap Health Care ETF (PSCH), Roundhill Acquirers Deep Value ETF (DEEP), Pacer US Small Cap Cash Cows 100 ETF (CALF), Distillate Small/Mid Cash Flow ETF (DSMC), Syntax Stratified SmallCap ETF (SSLY), First Trust Small Cap Value AlphaDEX Fund (FYT) and iShares S&P Small-Cap 600 Value ETF (IJS). What is Mark S. Ordan's approval rating as Pediatrix Medical Group's CEO? 6 employees have rated Pediatrix Medical Group Chief Executive Officer Mark S. Ordan on Glassdoor.com. Mark S. Ordan has an approval rating of 34% among the company's employees. This puts Mark S. Ordan in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Pediatrix Medical Group own? Based on aggregate information from My MarketBeat watchlists, some companies that other Pediatrix Medical Group investors own include NVIDIA (NVDA), AbbVie (ABBV), QUALCOMM (QCOM), Gilead Sciences (GILD), Pfizer (PFE), AT&T (T), Walt Disney (DIS), Wells Fargo & Company (WFC), Exxon Mobil (XOM) and Advanced Micro Devices (AMD). What is Pediatrix Medical Group's stock symbol? Pediatrix Medical Group trades on the New York Stock Exchange (NYSE) under the ticker symbol "MD." Who are Pediatrix Medical Group's major shareholders? Pediatrix Medical Group's stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (16.10%), Dimensional Fund Advisors LP (4.61%), State Street Corp (4.08%), ArrowMark Colorado Holdings LLC (3.15%), River Road Asset Management LLC (1.91%) and Geode Capital Management LLC (1.85%). Insiders that own company stock include John C Pepia, Mark S Ordan, Nicholas J Nikolopoulos, Roger Mack Hinson, Roger Md Medel and Shirley A Weis. View institutional ownership trends. How do I buy shares of Pediatrix Medical Group? Shares of MD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Pediatrix Medical Group's stock price today? One share of MD stock can currently be purchased for approximately $13.36. How much money does Pediatrix Medical Group make? Pediatrix Medical Group (NYSE:MD) has a market capitalization of $1.12 billion and generates $1.97 billion in revenue each year. The company earns $66.33 million in net income (profit) each year or $1.22 on an earnings per share basis. How many employees does Pediatrix Medical Group have? The company employs 5,250 workers across the globe. How can I contact Pediatrix Medical Group? Pediatrix Medical Group's mailing address is 1301 CONCORD TERRACE, SUNRISE FL, 33323. The official website for the company is www.mednax.com. The company can be reached via phone at (954) 384-0175, via email at charles_lynch@mednax.com, or via fax at 954-838-9961. This page (NYSE:MD) was last updated on 5/29/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pediatrix Medical Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.